Applications
Sulfa Drugs using Synergi 4u Polar RP
15906
Separation Mode: Reversed Phase
Reversed Phase
Polar-RP
HPLC
Anti-Infective Agents
Pharmaceutical
Therapeutic / Clinical

Applications

Sulfa Drugs using Synergi 4u Polar RP

Analytes

1
2
3
Compound Name
Sulfathiazole
CID
5340
Molecular Formula
C9H9N3O2S2
Molecular Weight
255
No. Hydrogen Bond Acceptors
5
No. Hydrogen Bond Donors
2

Conditions

LC Conditions (App ID: 15906)
Column:Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
Brand Name:Synergi
Part No:00F-4336-E0
Elution Type:Isocratic
Mobile Phase:A: 0.1% Formic Acid in Water
B: Methanol
Gradient Profile:
Step No.Time(min)%A%B
107030
Flow Rate:1 mL/min
Temperature:22°C
Detection:UV-Vis Abs.-Variable Wave.(UV) nm @ 22°C

Order Items Used in This Application

Similar Applications
No Data